Interestingly, emerging data in the literature suggest kallikreins may be directly involved in neoplastic progression by negatively regulating tumor growth in breast and colon cancers (Borgoño and Diamandis, 2004). This evidence concerns the gene KLK4 and colonic neoplasm.